NASDAQ:PEPG PepGen (PEPG) Stock Price, News & Analysis $8.83 -0.03 (-0.34%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$8.75▼$9.2750-Day Range$7.75▼$18.5552-Week Range$3.72▼$19.30Volume208,464 shsAverage Volume128,396 shsMarket Capitalization$286.24 millionP/E RatioN/ADividend YieldN/APrice Target$19.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get PepGen alerts: Email Address PepGen MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside119.0% Upside$19.33 Price TargetShort InterestBearish3.14% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$710,169 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($3.16) to ($2.82) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.01 out of 5 starsMedical Sector770th out of 910 stocksPharmaceutical Preparations Industry360th out of 426 stocks 3.3 Analyst's Opinion Consensus RatingPepGen has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoveragePepGen has only been the subject of 3 research reports in the past 90 days.Read more about PepGen's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.14% of the float of PepGen has been sold short.Short Interest Ratio / Days to CoverPepGen has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in PepGen has recently increased by 36.52%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPepGen does not currently pay a dividend.Dividend GrowthPepGen does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PEPG. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for PepGen this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added PepGen to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PepGen insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $710,169.00 in company stock.Percentage Held by InsidersOnly 4.60% of the stock of PepGen is held by insiders.Percentage Held by Institutions58.01% of the stock of PepGen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PepGen's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for PepGen are expected to grow in the coming year, from ($3.16) to ($2.82) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PepGen is -2.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PepGen is -2.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPepGen has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about PepGen's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Sasco Gold LLCSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... [RUSH MY FREE GUIDE] About PepGen Stock (NASDAQ:PEPG)PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.Read More PEPG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PEPG Stock News HeadlinesAugust 25, 2024 | stockhouse.comPepGen Inc Is Being Investigated For Securities Law Infractions And The Schall Law Firm Is Looking For Shareholders To ParticipateAugust 21, 2024 | finance.yahoo.comPepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & DevelopmentSeptember 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 20, 2024 | finance.yahoo.comPepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & DevelopmentAugust 17, 2024 | finance.yahoo.comIs PepGen Inc. (NASDAQ:PEPG) Trading At A 34% Discount?August 13, 2024 | uk.finance.yahoo.comPepGen Inc. (PEPG)August 13, 2024 | globenewswire.comPepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 9, 2024 | markets.businessinsider.comPEPG Stock Earnings: PepGen Misses EPS for Q2 2024September 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 8, 2024 | finance.yahoo.comPepGen Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 7, 2024 | globenewswire.comPepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 1, 2024 | markets.businessinsider.comBuy Rating Affirmed for PepGen Inc. as PGN-EDO51 Shows Promise in DMD Treatment LandscapeAugust 1, 2024 | markets.businessinsider.comOptimistic Outlook on PepGen’s DMD Therapy Despite Initial Data: Analyst Reiterates Buy RatingJuly 31, 2024 | tmcnet.comPEPG Investors Have Opportunity to Join PepGen Inc. Securities Fraud Investigation with the Schall Law FirmJuly 31, 2024 | finance.yahoo.comPepGen reports positive data from Phase II Duchenne muscular dystrophy trialJuly 31, 2024 | seekingalpha.comPepGen: EDOs Could Enhance Dystrophin Expression Beyond Scope Of Current TreatmentsJuly 21, 2024 | investing.comPepGen's chief medical officer sells shares worth over $229kJune 11, 2024 | businesswire.comPepGen Announces Executive Team PromotionsSee More Headlines Receive PEPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PepGen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:PEPG CUSIPN/A CIK1835597 Webwww.pepgen.com Phone781-797-0979FaxN/AEmployees64Year FoundedN/APrice Target and Rating Average Stock Price Target$19.33 High Stock Price Target$26.00 Low Stock Price Target$12.00 Potential Upside/Downside+119.0%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($3.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,630,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-62.74% Return on Assets-50.37% Debt Debt-to-Equity RatioN/A Current Ratio7.45 Quick Ratio7.45 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.55 per share Price / Book1.94Miscellaneous Outstanding Shares32,417,000Free Float30,926,000Market Cap$286.24 million OptionableNot Optionable Beta1.70 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. James G. McArthur Ph.D. (Age 62)President, CEO, Treasurer, Secretary & Director Comp: $834.98kMr. Noel P. Donnelly M.B.A. (Age 54)Chief Financial Officer Comp: $650.17kMr. Niels Svenstrup Ph.D. (Age 54)Senior Vice President of Chemistry, Manufacturing & Control Comp: $455.15kDr. Michael Gait Ph.D.Founder & Scientific Advisory Board MemberMs. Emiko BryantChief of StaffMr. Kyle BreidenstineVP of Finance & ControllerMore ExecutivesKey CompetitorsDay One BiopharmaceuticalsNASDAQ:DAWNTango TherapeuticsNASDAQ:TNGXProthenaNASDAQ:PRTAGyre TherapeuticsNASDAQ:GYRETyra BiosciencesNASDAQ:TYRAView All CompetitorsInsiders & InstitutionsPoint72 Asset Management L.P.Sold 47,004 shares on 8/19/2024Ownership: 0.448%Marshall Wace LLPBought 12,251 shares on 8/14/2024Ownership: 0.038%Point72 DIFC LtdBought 2,621 shares on 8/14/2024Ownership: 0.008%Sofinnova Investments Inc.Bought 57,504 shares on 8/10/2024Ownership: 1.731%Renaissance Technologies LLCBought 12,000 shares on 8/9/2024Ownership: 0.037%View All Insider TransactionsView All Institutional Transactions PEPG Stock Analysis - Frequently Asked Questions How have PEPG shares performed this year? PepGen's stock was trading at $6.80 on January 1st, 2024. Since then, PEPG stock has increased by 29.9% and is now trading at $8.83. View the best growth stocks for 2024 here. How were PepGen's earnings last quarter? PepGen Inc. (NASDAQ:PEPG) released its quarterly earnings results on Thursday, August, 8th. The company reported ($0.87) earnings per share for the quarter, missing analysts' consensus estimates of ($0.72) by $0.15. When did PepGen IPO? PepGen (PEPG) raised $126 million in an IPO on Friday, May 6th 2022. The company issued 9,000,000 shares at a price of $13.00-$15.00 per share. Who are PepGen's major shareholders? Top institutional investors of PepGen include Sofinnova Investments Inc. (1.73%), Point72 Asset Management L.P. (0.45%), Bank of New York Mellon Corp (0.14%) and American Century Companies Inc. (0.06%). Insiders that own company stock include Ra Capital Management, LP, James G Mcarthur, Jaya Goyal, Michelle L Mellion and Niels Svenstrup. View institutional ownership trends. How do I buy shares of PepGen? Shares of PEPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PEPG) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PEPG Stock Alerts